These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 26039047

  • 1. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.
    Kanaoka R, Kushiyama A, Seno Y, Nakatsu Y, Matsunaga Y, Fukushima T, Tsuchiya Y, Sakoda H, Fujishiro M, Yamamotoya T, Kamata H, Matsubara A, Asano T.
    PLoS One; 2015; 10(6):e0127467. PubMed ID: 26039047
    [Abstract] [Full Text] [Related]

  • 2. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.
    Chen SY, Wulf G, Zhou XZ, Rubin MA, Lu KP, Balk SP.
    Mol Cell Biol; 2006 Feb; 26(3):929-39. PubMed ID: 16428447
    [Abstract] [Full Text] [Related]

  • 3. Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis.
    Endoh K, Nishi M, Ishiguro H, Uemura H, Miyagi Y, Aoki I, Hirano H, Kubota Y, Ryo A.
    Prostate; 2012 May 01; 72(6):626-37. PubMed ID: 21809350
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
    Lee KH, Lin FC, Hsu TI, Lin JT, Guo JH, Tsai CH, Lee YC, Lee YC, Chen CL, Hsiao M, Lu PJ.
    Biochim Biophys Acta; 2014 Sep 01; 1843(9):2055-66. PubMed ID: 24915000
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas.
    Wiegand S, Dakic B, Rath AF, Makarova G, Sterz C, Meissner W, Bette M, Adamkiewicz J, Müller-Brüsselbach S, Müller R, Werner JA, Mandic R.
    Oral Oncol; 2009 Oct 01; 45(10):e140-9. PubMed ID: 19502098
    [Abstract] [Full Text] [Related]

  • 8. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
    Mathur R, Chandna S, N Kapoor P, S Dwarakanath B.
    Curr Cancer Drug Targets; 2011 Mar 01; 11(3):380-92. PubMed ID: 21247380
    [Abstract] [Full Text] [Related]

  • 9. Prolyl-isomerase Pin1 impairs trastuzumab sensitivity by up-regulating fatty acid synthase expression.
    Yun HJ, Kim JY, Kim G, Choi HS.
    Anticancer Res; 2014 Mar 01; 34(3):1409-16. PubMed ID: 24596388
    [Abstract] [Full Text] [Related]

  • 10. Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family.
    Fan G, Fan Y, Gupta N, Matsuura I, Liu F, Zhou XZ, Lu KP, Gélinas C.
    Cancer Res; 2009 Jun 01; 69(11):4589-97. PubMed ID: 19458071
    [Abstract] [Full Text] [Related]

  • 11. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription.
    Chao SH, Greenleaf AL, Price DH.
    Nucleic Acids Res; 2001 Feb 01; 29(3):767-73. PubMed ID: 11160900
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
    Ghosh A, Saminathan H, Kanthasamy A, Anantharam V, Jin H, Sondarva G, Harischandra DS, Qian Z, Rana A, Kanthasamy AG.
    J Biol Chem; 2013 Jul 26; 288(30):21955-71. PubMed ID: 23754278
    [Abstract] [Full Text] [Related]

  • 14. Pin1 inhibitor Juglone prevents diabetic vascular dysfunction.
    Costantino S, Paneni F, Lüscher TF, Cosentino F.
    Int J Cardiol; 2016 Jan 15; 203():702-7. PubMed ID: 26583846
    [Abstract] [Full Text] [Related]

  • 15. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.
    Prostate; 2006 Jul 01; 66(10):1070-5. PubMed ID: 16637076
    [Abstract] [Full Text] [Related]

  • 16. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
    Lam PB, Burga LN, Wu BP, Hofstatter EW, Lu KP, Wulf GM.
    Mol Cancer; 2008 Dec 15; 7():91. PubMed ID: 19077306
    [Abstract] [Full Text] [Related]

  • 17. Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin.
    Liu Z, Marquez M, Nilsson S, Holmberg AR.
    Oncol Rep; 2009 Dec 15; 22(6):1451-8. PubMed ID: 19885599
    [Abstract] [Full Text] [Related]

  • 18. Effect of Pin1 inhibitor juglone on proliferation, migration and angiogenic ability of breast cancer cell line MCF7Adr.
    Hu YG, Shen YF, Li Y.
    J Huazhong Univ Sci Technolog Med Sci; 2015 Aug 15; 35(4):531-534. PubMed ID: 26223922
    [Abstract] [Full Text] [Related]

  • 19. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
    Mizutani N, Inoue M, Omori Y, Ito H, Tamiya-Koizumi K, Takagi A, Kojima T, Nakamura M, Iwaki S, Nakatochi M, Suzuki M, Nozawa Y, Murate T.
    J Biochem; 2015 Oct 15; 158(4):309-19. PubMed ID: 25888580
    [Abstract] [Full Text] [Related]

  • 20. Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation.
    Lim YS, Tran HT, Park SJ, Yim SA, Hwang SB.
    J Virol; 2011 Sep 15; 85(17):8777-88. PubMed ID: 21680504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.